Quote Originally Posted by Sawin View Post
I believe JD and anything to do with Crispr like EDIT and NTLA stand a good chance at being such opportunities... I am holding all 3 for the long term.


Thanks for the great tip, and I will initiate the HW. It is not the sector/ind I am huge fan of anymore (pharma/biotech), but definitely would love to start the heavily beat up (distressed) or ones with good potentials.